Figures & data
Table 1 Subtests of the HIV Dementia Scale and International HIV Dementia Scale
Table 2 Summary of three meta-analyses of the accuracy of the HDS and IHDS
Table 3 Calculation of posttest probability of HAND using the HDS and IHDS, under three different fictional scenarios
Table 4 Summary of results from studies of diagnostic accuracy of the MoCA at standard cutoff (26 points)
Power C, Selnes OA, Grim JA, McArthur JC. HIV dementia scale: a rapid screening test. J Acquir Immune Defic Syndr. 1995;8(3):273–278. Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–1374. Hu X, Zhou Y, Long J, et al. Diagnostic accuracy of the International HIV Dementia Scale and HIV dementia scale: a meta-analysis. Exp Ther Med. 2012;4(4):665–668. Zipursky AR, Gogolishvili D, Rueda S, et al. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS. 2013;27(15):2385–2401. Haddow LJ, Floyd S, Copas A, Gilson RJ. A systematic review of the diagnostic accuracy of the HIV dementia scale and International HIV Dementia Scale. PLoS One. 2013;8(4):e61826. Joska JA, Witten J, Thomas KG, et al. A comparison of five brief screening tools for HIV-associated neurocognitive disorders in the USA and South Africa. AIDS Behav. 2016;20. Epub 2016 Feb 9. Hasbun R, Eraso J, Ramireddy S, et al. Screening for neurocognitive impairment in HIV individuals: the utility of the Montreal Cognitive Assessment test. J AIDS Clin Res. 2012;3(10):186. Janssen MA, Bosch M, Koopmans PP, Kessels RP. Validity of the Montreal Cognitive Assessment and the HIV dementia scale in the assessment of cognitive impairment in HIV-1 infected patients. J Neurovirol. 2015;21(4):383–390. Overton ET, Azad T, Parker N, et al. The Alzheimer disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol. 2013;19(1):109–116. Milanini B, Wendelken LA, Esmaeili-Firidouni P, Chartier M, Crouch P-C, Valcour V. The Montreal Cognitive Assessment (MoCA) to screen for cognitive impairment in HIV over age 60. J Acquir Immune Defic Syndr. 2014;67(1):67–70. Ku NS, Lee Y, Ahn JY, et al. HIV-associated neurocognitive disorder in HIV-infected Koreans: Korean NeuroAIDS Project. HIV Med. 2014;15(8):470–477.